Intussusception among infants given an oral rotavirus vaccine.

By T. Murphy, P. Gargiullo, M. Massoudi, D. Nelson, A. Jumaan, Catherine A. Okoro, L. Zanardi, Sabeena Setia, E. Fair, C. Lebaron and 3 more. New England Journal of Medicine, 2001

949 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Surgery

View Paper: https://www.semanticscholar.org/paper/66e395d8b1448943edd7e8361edb3e81c4af750c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Bresee
2. R. Glass
3. M. Cortese
4. Umesh D. Parashar
5. Heather J. Whitaker
6. Mark A. Miller
7. W. Ray
8. C. Paddy Farrington

Citations in the corpus

• Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). (2009, background): “The risk for intussusception was most elevated (>20-fold increase) within 3-14 days after receipt of dose 1 of RRV-TV, with a smaller (approximately fivefold) increase in risk within 3-14 days after receipt of dose 2 (84).”
• Global Illness and Deaths Caused by Rotavirus Disease in Children (2003, background): “However, 9 months later, the use of Rotashield was suspended because reports suggested a possible association with intussusception (4).”
• Evaluating medication effects outside of clinical trials: new-user designs. (2003, background): “Am J Epidemiol 2003;158:915–920 following administration of rotavirus vaccine (17), for falls”
• Tutorial in biostatistics: the self‐controlled case series method (2006, background): “[30] DTP∗, MMR†, HBV Wheezing Mullooly et al.”